Literature DB >> 15689924

Neonatal cholestasis associated with fetal arrhythmia.

Ana Maria Sant'Anna1, Jean-Claude Fouron, Fernando Alvarez.   

Abstract

We evaluated the consequence of different types of fetal arrhythmia in the development of neonatal cholestasis. The charts of 38 children born at St. Justine Hospital between 1993 and 2001 with sustained and hemodynamically significant fetal arrhythmias were studied: 19 with supraventricular tachycardia, 14 with atrial flutter, and 5 with atrio-ventricular (AV) block. Six of these 38 children presented with cholestasis. The average duration of arrhythmia was 15.7 days in the noncholestatic group, compared with 40.3 days in the cholestatic group ( P <.05). The three infants with supraventricular tachycardia who developed cholestasis survived and resolved their cholestasis, whereas 2 of 3 infants with AV block died. No infant with atrial flutter developed cholestasis. We conclude that newborns who developed tachyarrhythmia during their fetal life can show transient neonatal cholestasis. In patients with AV block, severe and irreversible liver failure could be observed. In addition, extensive collapse of the stroma and the absence of hepatocytes (foie vide) also were observed in a patient with anti-Ro antibodies.

Entities:  

Mesh:

Year:  2005        PMID: 15689924     DOI: 10.1016/j.jpeds.2004.10.024

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  2 in total

1.  Embryonic stem cell-derived cardiomyocytes as a model to study fetal arrhythmia related to maternal disease.

Authors:  Siti H Sheikh Abdul Kadir; Nadire N Ali; Maxime Mioulane; Marta Brito-Martins; Shadi Abu-Hayyeh; Gabor Foldes; Alexey V Moshkov; Catherine Williamson; Sian E Harding; Julia Gorelik
Journal:  J Cell Mol Med       Date:  2009-03-06       Impact factor: 5.310

2.  Presentation and Outcomes of Infants With Idiopathic Cholestasis: A Multicenter Prospective Study.

Authors:  Paula M Hertel; Kieran Hawthorne; Sehee Kim; Milton J Finegold; Benjamin L Shneider; James E Squires; Nitika A Gupta; Laura N Bull; Karen F Murray; Nanda Kerkar; Vicky L Ng; Jean P Molleston; Jorge A Bezerra; Kathleen M Loomes; Sarah A Taylor; Kathleen B Schwarz; Yumirle P Turmelle; Philip Rosenthal; John C Magee; Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-10-01       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.